No Image

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

SHANGHAI, China, Sept. 19, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (FDA) has expanded the emergency use authoriza...
read more
No Image

CORONAVIRUS/EVA Air, preschool COVID-19 clusters nearly at an end: CECC

The Central Epidemic Command Center (CECC) has determined that a small cluster of COVID-19 infections involving EVA Airways pilots is under control, while another cluster linked to a preschool has likely also run its course.There have been no new cases...
read more
No Image

CORONAVIRUS/COVID-positive pilot fined NT$400,000 for violating quarantine rules

A pilot who was recently confirmed with the Delta variant of the COVID-19 virus and dismissed by EVA Airways has been slapped with a fine of NT$400,000 (US$14,440) for violating quarantine rules.In a statement released Friday, the Civil Aeronautics Adm...
read more